Rikke Lindhardt at Gerresheimer explains how constant focus on children safety and prevention of serious accidents seems to play a crucial role when choosing primary plastic pharmaceutical packaging.
Dr Kamal Badiani at Pepceuticals provides an overview of why peptides have long been regarded as crucial to offering solutions to mounting and increasingly difficult world health issues, and the possibility of patient-specific therapy.
Chris Hansford at Hansford Sensors Ltd explains why vibration sensing is one of the oldest solutions in the engineering workplace, with a lineage that outstrips other technologies by centuries.
Iqbal T Shadi from Imperial College London NHLI and Roy Goodacre, Professor of Biological Chemistry at University of Manchester, explore how Raman spectroscopy has advanced in recent years, and how its use in both industry and academia has increased significantly and is redrawing the landscape in many fields, such as biomedical and pharmaceutical R&D.
Harry Abts at Merz Pharmaceuticals GmbH provides an overview of why the oxygen and pH kinetics give valuable information about culture quality and efficiency. The SDR SensorDish Reader allows precise, non-invasive analysis of the process parameters dissolved oxygen (DO) and pH in cell culture.
Abbes Kacimi at Sofrigam explores why samples must be transported in accordance with IATA regulations for the air transport of dangerous goods, and with the European agreement concerning the International Carriage of Dangerous Goods by Road.
Jim Hardisty at Go Plastic Pallets discusses how poorly chosen pallets can seriously compromise safety in pharmaceutical supply chains and can lead to unnecessary costs.
The objective of this study by Jennifer Ammerman, Chaoyang Huang, Daniel Wright at MPI Research was to validate a bioanalytical method for the quantitation of potassium in human urine samples obtained from clinical studies; with patients dosed with potassium chloride in support of required bioequivalence studies.
Personalised medicine is not yet fully implemented in healthcare developments and the reasons might be scientific, technological, financial, regulatory or ethical. Thibault Helleputte at DNAlytics outlines recent trends regarding them and discusses the observation that relates to data science – or the lack of it – in current practice.
Vikki Brandi at Quintiles discusses key methodological, practical and ethical issues in the conduct of CF clinical trials with a focus on site identification, feasibility and clinical research studies.
